Acumen Pharmaceuticals Stock Price History
ABOS Stock | USD 2.31 0.06 2.53% |
If you're considering investing in Acumen Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acumen Pharmaceuticals stands at 2.31, as last reported on the 22nd of November, with the highest price reaching 2.40 and the lowest price hitting 2.25 during the day. Acumen Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0561, which signifies that the company had a -0.0561% return per unit of risk over the last 3 months. Acumen Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Acumen Pharmaceuticals' Mean Deviation of 3.5, standard deviation of 4.69, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide.
Stock Based Compensation is likely to gain to about 6.5 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 143.2 M in 2024. . At this time, Acumen Pharmaceuticals' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 0.73 in 2024, whereas Price Earnings Ratio is likely to drop (3.73) in 2024. Acumen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acumen |
Sharpe Ratio = -0.0561
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ABOS |
Estimated Market Risk
4.78 actual daily | 42 58% of assets are more volatile |
Expected Return
-0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Acumen Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acumen Pharmaceuticals by adding Acumen Pharmaceuticals to a well-diversified portfolio.
Price Book 0.6556 | Enterprise Value Ebitda (0.60) | Price Sales 538.7842 | Shares Float 32.4 M | Wall Street Target Price 10.8 |
Acumen Pharmaceuticals Stock Price History Chart
There are several ways to analyze Acumen Stock price data. The simplest method is using a basic Acumen candlestick price chart, which shows Acumen Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 8, 2024 | 3.27 |
Lowest Price | September 6, 2024 | 2.22 |
Acumen Pharmaceuticals November 22, 2024 Stock Price Synopsis
Various analyses of Acumen Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Acumen Stock. It can be used to describe the percentage change in the price of Acumen Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Acumen Stock.Acumen Pharmaceuticals Price Rate Of Daily Change | 0.97 | |
Acumen Pharmaceuticals Price Daily Balance Of Power | (0.40) | |
Acumen Pharmaceuticals Price Action Indicator | (0.04) | |
Acumen Pharmaceuticals Accumulation Distribution | 8,065 |
Acumen Pharmaceuticals November 22, 2024 Stock Price Analysis
Acumen Stock Price History Data
The price series of Acumen Pharmaceuticals for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 1.05 with a coefficient of variation of 10.26. The prices are distributed with arithmetic mean of 2.62. The median price for the last 90 days is 2.53.Open | High | Low | Close | Volume | ||
11/21/2024 | 2.40 | 2.40 | 2.25 | 2.31 | 129,047 | |
11/20/2024 | 2.42 | 2.45 | 2.32 | 2.37 | 180,507 | |
11/19/2024 | 2.23 | 2.39 | 2.23 | 2.39 | 146,848 | |
11/18/2024 | 2.40 | 2.46 | 2.24 | 2.24 | 225,276 | |
11/15/2024 | 2.62 | 2.62 | 2.37 | 2.40 | 296,509 | |
11/14/2024 | 2.57 | 2.66 | 2.41 | 2.61 | 202,922 | |
11/13/2024 | 2.73 | 2.74 | 2.52 | 2.53 | 182,197 | |
11/12/2024 | 3.20 | 3.20 | 2.55 | 2.68 | 431,142 | |
11/11/2024 | 3.36 | 3.36 | 3.11 | 3.22 | 190,208 | |
11/08/2024 | 3.19 | 3.29 | 3.15 | 3.27 | 160,375 | |
11/07/2024 | 3.23 | 3.29 | 3.16 | 3.17 | 179,466 | |
11/06/2024 | 3.02 | 3.30 | 2.85 | 3.23 | 392,763 | |
11/05/2024 | 2.96 | 3.02 | 2.95 | 3.00 | 106,271 | |
11/04/2024 | 2.84 | 3.05 | 2.79 | 2.95 | 198,629 | |
11/01/2024 | 2.89 | 2.94 | 2.79 | 2.85 | 104,417 | |
10/31/2024 | 3.04 | 3.04 | 2.85 | 2.88 | 158,133 | |
10/30/2024 | 2.90 | 3.14 | 2.84 | 3.03 | 244,556 | |
10/29/2024 | 2.95 | 2.95 | 2.75 | 2.91 | 201,944 | |
10/28/2024 | 3.00 | 3.14 | 2.87 | 2.89 | 274,058 | |
10/25/2024 | 2.75 | 3.03 | 2.75 | 2.90 | 299,152 | |
10/24/2024 | 2.71 | 2.75 | 2.68 | 2.74 | 65,908 | |
10/23/2024 | 2.79 | 2.85 | 2.60 | 2.69 | 121,385 | |
10/22/2024 | 2.69 | 2.82 | 2.64 | 2.80 | 164,888 | |
10/21/2024 | 2.85 | 2.95 | 2.64 | 2.70 | 180,919 | |
10/18/2024 | 2.70 | 2.89 | 2.67 | 2.86 | 289,446 | |
10/17/2024 | 2.40 | 2.66 | 2.38 | 2.66 | 1,004,068 | |
10/16/2024 | 2.36 | 2.42 | 2.32 | 2.39 | 113,142 | |
10/15/2024 | 2.36 | 2.41 | 2.29 | 2.33 | 102,145 | |
10/14/2024 | 2.37 | 2.42 | 2.33 | 2.35 | 77,115 | |
10/11/2024 | 2.25 | 2.36 | 2.22 | 2.35 | 196,213 | |
10/10/2024 | 2.27 | 2.32 | 2.21 | 2.25 | 117,134 | |
10/09/2024 | 2.40 | 2.41 | 2.27 | 2.29 | 122,623 | |
10/08/2024 | 2.40 | 2.43 | 2.33 | 2.36 | 81,693 | |
10/07/2024 | 2.38 | 2.42 | 2.33 | 2.38 | 137,583 | |
10/04/2024 | 2.42 | 2.42 | 2.31 | 2.37 | 175,412 | |
10/03/2024 | 2.50 | 2.51 | 2.39 | 2.39 | 119,245 | |
10/02/2024 | 2.44 | 2.52 | 2.35 | 2.50 | 307,340 | |
10/01/2024 | 2.47 | 2.49 | 2.39 | 2.45 | 185,581 | |
09/30/2024 | 2.48 | 2.55 | 2.43 | 2.48 | 89,496 | |
09/27/2024 | 2.49 | 2.55 | 2.47 | 2.48 | 135,154 | |
09/26/2024 | 2.45 | 2.52 | 2.36 | 2.43 | 190,933 | |
09/25/2024 | 2.41 | 2.43 | 2.33 | 2.34 | 100,061 | |
09/24/2024 | 2.39 | 2.49 | 2.37 | 2.44 | 87,650 | |
09/23/2024 | 2.51 | 2.51 | 2.36 | 2.37 | 154,599 | |
09/20/2024 | 2.55 | 2.56 | 2.49 | 2.50 | 360,440 | |
09/19/2024 | 2.55 | 2.66 | 2.50 | 2.58 | 222,635 | |
09/18/2024 | 2.49 | 2.54 | 2.44 | 2.44 | 129,302 | |
09/17/2024 | 2.56 | 2.63 | 2.47 | 2.48 | 135,193 | |
09/16/2024 | 2.62 | 2.65 | 2.52 | 2.54 | 121,389 | |
09/13/2024 | 2.51 | 2.60 | 2.50 | 2.60 | 117,010 | |
09/12/2024 | 2.50 | 2.53 | 2.42 | 2.45 | 67,373 | |
09/11/2024 | 2.47 | 2.55 | 2.42 | 2.47 | 115,945 | |
09/10/2024 | 2.41 | 2.54 | 2.38 | 2.51 | 119,330 | |
09/09/2024 | 2.23 | 2.44 | 2.23 | 2.44 | 193,523 | |
09/06/2024 | 2.26 | 2.27 | 2.15 | 2.22 | 324,831 | |
09/05/2024 | 2.37 | 2.42 | 2.27 | 2.27 | 287,933 | |
09/04/2024 | 2.45 | 2.53 | 2.38 | 2.40 | 241,015 | |
09/03/2024 | 2.70 | 2.81 | 2.44 | 2.45 | 256,920 | |
08/30/2024 | 2.80 | 2.85 | 2.63 | 2.74 | 232,256 | |
08/29/2024 | 2.80 | 2.92 | 2.76 | 2.81 | 128,408 | |
08/28/2024 | 2.78 | 2.83 | 2.73 | 2.77 | 105,031 |
About Acumen Pharmaceuticals Stock history
Acumen Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acumen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acumen Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acumen Pharmaceuticals stock prices may prove useful in developing a viable investing in Acumen Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 48.6 M | 46.2 M | |
Net Loss | -38.6 M | -40.5 M |
Acumen Pharmaceuticals Quarterly Net Working Capital |
|
Acumen Pharmaceuticals Stock Technical Analysis
Acumen Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
All Next | Launch Module |
Acumen Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acumen Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Acumen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acumen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.43) | |||
Total Risk Alpha | (0.70) | |||
Treynor Ratio | (0.05) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.